Illumina Inc (ILMN)
$432.08
11.53 (2.74%)
18:26 EST
ILMN Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
63.52B
PE Ratio
112.23
EPS
3.85
Volume (Avg. Vol.)
2.23M
Day's Range
406.84 - 434.94
52-Week Range
196.78 - 434.94
Dividend & Yield
N/A (N/A)
ILMN Stock Predictions, Articles, and Illumina Inc News
- From InvestorPlace
- From the Web
7 Healthcare Stocks to Buy With the Sector Under Scrutiny
True, there are political risks in the industry. But there are also lots of growth opportunities for investors in healthcare stocks.
7 Unhealthy Biotech Stocks To Sell Before They Sicken Your Portfolio
It’s a good time to separate the weak from the strong.
Illumina News: ILMN Stock Slides Lower on $8 Billion Grail Deal
Illumina's news of its $8 billion deal to acquire Grail, a healthcare company focused on cancer detection, has ILMN stock down on Monday.
Illumina News: ILMN Stock 4% Lower on Weak 2020 Outlook
Illumina (ILMN) news for Monday includes ILMN stock falling on a weak outlook for 2020, as well as some other news about a deal.
Investors Should Wait for Sky-High Valuations on Illumina Stock to Deflate
You pay a high price for a company with near monopoly like Illumina. ILMN stock has 70% market share, but Its valuation is too high.
VIDEO: Biotech Stocks and the Future of Healthcare
Tune in to 'Moneyline' to learn more about new opportunities in biotech stocks and how else to invest in the future of healthcare.
Nasdaq Today: Amazon Prime Day; Facebook Settles With FTC
Facebook is reportedly settling with the FTC, Illumina warns on earnings and Amazon Prime Day is nearing in the Nasdaq Today.
4 Top Stock Trades for Monday:JNJ, SQ, ILMN, ACB
Square, Johnson & Johnson, Illumina, Canopy Growth and Aurora Cannabis are our top stock trades for Monday.
Illumina News: Why ILMN Stock Is Plummeting
Illumina news for Friday concerning early results for the second quarter of 2019 that are below estimates is hitting ILMN stock hard.
Nasdaq Today: Apple Loses Ive and the Nasdaq’s Q3 Outlook
The second quarter is the books, at least as far as the stock market is concerned. Here's a look at the Nasdaq today.
8 Genomic Testing Stocks That Can Ease the Sting of Theranos
InVitae, Crispr and Myriad are just some of the genomic testing stocks worth a look as DNA becomes a more important part of healthcare.
10 Smart Money Stocks to Buy Now
Hedge funds have just released their trades for the fourth quarter, indicating some of the best stocks to buy now.
10 Stocks to Sell in February
Alphabet, Fiserv and Caterpillar are three of the 10 stocks you have to sell to sidestep trouble in the immediate future.
10 Stocks That Can Move Higher Whatever Happens
Morgan Stanley says these stocks are set to outperform even if the market slows down in 2019. That makes these 10 excellent stocks to buy for careful investors.
3 DNA Stocks That Are on the Uptrend
The future of genetic medicine is bright, but bumpy. But these bumps will provide many opportunities to buy DNA stocks along the way.
Nasdaq ETF Hits New Highs: 5 Stocks Up More Than 50%
Though most of the stocks in the Nasdaq ETF portfolio delivered strong returns so far this year, a few were the real stars, having gained more than 50%. Compare....
5 Top Stocks Likely to Beat Earnings Estimates
These top-ranked stocks are likely to beat on bottom line in their next releases. Compare Brokers....
7 Momentum Stocks That Will Power Through 2018
Each case for these momentum stocks is backed by Wall Street's top analysts and the stocks should continue to power through 2018 and beyond.
15 Stocks in the FANG Junior-Varsity League
These 15 junior-varsity FANG stocks have an opportunity to one day become as big and recognizable as the actual FANG stocks are today.
4 Best Efficient Stocks to Add to Your Portfolio
A company with a favorable efficiency level is expected to provide stellar returns as it is believed to be positively correlated with price performance. Compare....
The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement
From
Benzinga

Navellier Ratings
Powered by Portfolio GraderTotal Grade
C
Hold